HuGE Literature Finder
Records
1
-
12
ERBB2 exon 20 insertions are rare in Brazilian non-small cell lung cancer. Thoracic cancer 2022 Oct . de Oliveira Cavagna Rodrigo, Zaniolo Beatriz Garbe, de Paula Flávia Escremim, Berardinelli Gustavo Noriz, Santana Iara, da Silva Eduardo Caetano Albino, Dias Josiane Mourão, Jacinto Alexandre Arthur, da Nóbrega Oliveira Rachid Eduardo Noleto, de Marchi Pedro, Leal Letícia Ferro, Reis Rui Manu |
Genotyping of cerebrospinal fluid in lung cancer patients with leptomeningeal metastasis. Thoracic cancer 2022 Sep 13 (18): 2574-2583. Nie Naifu, Zhou Haodong, Zhang Kejun, Liu Lan, Luo Nuo, Wang Renyuan, Li Xin, Zhu Mengxiao, Hu Chen, Wang Yubo, Liu Zhulin, Li Li, He Yo |
Clinicopathological and prognostic implications of ALK rearrangement in patients with completely surgically resected lung adenocarcinoma. Thoracic cancer 2021 Oct . Zhang Huan, Shan Guangyao, Cai Benjie, Bi Guoshu, Chen Zhencong, Liang Jiaqi, Besskaya Valeria, Zheng Yuansheng, Guo Weigang, Wang Lin, Xu Songtao, Zhan Che |
Comprehensive genomic profiling of Brazilian non-small cell lung cancer patients (GBOT 0118/LACOG0418). Thoracic cancer 2020 Dec . Mascarenhas Eldsamira, Gelatti Ana Caroline, Araújo Luiz Henrique, Baldotto Clarissa, Mathias Clarissa, Zukin Mauro, Werutsky Gustavo, Pacheco Patricia, Gomes Rafaela, de Castro Gilberto, de Lima Vladmir Cordei |
Status of 10 targeted genes of non-small cell lung cancer in eastern China: A study of 884 patients based on NGS in a single institution. Thoracic cancer 2020 Jul . Li Dan, Ding Li, Ran Wenwen, Huang Yan, Li Guangqi, Wang Chengqin, Xiao Yujing, Wang Xiaonan, Lin Dongliang, Xing Xiaomi |
Response rate of patients with baseline brain metastases from recently diagnosed non-small cell lung cancer receiving radiotherapy according to EGFR, ALK and KRAS mutation status. Thoracic cancer 2020 Feb . Arrieta Oscar, Ramírez-Tirado Laura-Alejandra, Caballé-Perez Enrique, Mejia-Perez Alberto, Zatarain-Barrón Zyanya Lucia, Cardona Andrés F, Lozano-Ruíz Francisco, Segura-González Manuel, Cruz-Rico Graciela, Maldonado Federico, Rosell Rafa |
The prognostic implications of EGFR mutation and ALK rearrangement for the long-term outcomes of patients with resected lung adenocarcinomas. Thoracic cancer 2019 Jun . Kim Hyungjin, Lee Hyun-Ju, Hong Hyunsook, Kim Young Jae, Kim Kwang Gi, Jeon Yoon Kyung, Kim Young T |
Lung cancer family history and exposure to occupational/domestic coal combustion contribute to variations in clinicopathologic features and gene fusion patterns in non-small cell lung cancer. Thoracic cancer 2019 (4): 695-707. Chen Ying, Li Guangjian, Lei Yujie, Yang Kaiyun, Niu Huatao, Zhao Jie, He Rui, Ning Huanqi, Huang Qiubo, Zhou Qinghua, Huang Yunch |
PD-L1 expression in ROS1-rearranged non-small cell lung cancer: A study using simultaneous genotypic screening of EGFR, ALK, and ROS1. Thoracic cancer 2019 01 10 (1): 103-110. Lee Jongmin, Park Chan Kwon, Yoon Hyoung-Kyu, Sa Young Jo, Woo In Sook, Kim Hyo Rim, Kim Sue Youn, Kim Tae-Ju |
Clonally-related primary ALK rearranged adenocarcinoma and associated metastatic lesions. Thoracic cancer 2018 May . Zhu You-Cai, Deng Yun-Te, Wang Wen-Xian, Xu Chun-Wei, Zhuang Wu, Du Kai- |
Clinicopathological features of younger (aged = 50 years) lung adenocarcinoma patients harboring the EML4-ALK fusion gene. Thoracic cancer 2018 Mar . Kometani Takuro, Sugio Kenji, Osoegawa Atsushi, Seto Takashi, Ichinose Yuki |
Expression and copy number gains of the RET gene in 631 early and mid stage non-small cell lung cancer cases. Thoracic cancer 2018 Feb . Tan Ling, Hu Yerong, Tao Yongguang, Wang Bin, Xiao Jun, Tang Zhenjie, Lu Ting, Tang H |
- Page last reviewed:Jul 25, 2022
- Page last updated:Jan 27, 2023
- Content source: